Welcome to the largest Life Science Invest and Partnering meeting in the Nordic region!
The Nordic region is proud to host some of the world’s most innovative biotech, medtech and pharma companies. It also has the 12th strongest economy, making it the perfect place to invest. Set in the idyllic city of Stockholm, the conference offers conference sessions, panel discussions, company presentations, exhibition, face-to-face meetings and unique receptions, providing so many opportunities to network with peers, potential partners and investors.
What's new in 2015?
We welcome ScanBalt BioRegion, Swedish Medtech and LIF as special co-hosts. Together we invite companies throughout the Nordic and Baltic Sea regions to network, partner and showcase together in Stockholm.
The 2015 conference design will feature a new Exhibition layout creating more interactions with the exhibitors, an enriched program featuring 10 Super Sessions and 4 topical Workshops, an innovative Company Presentation format bringing more value to the presenters and the audience, new Partnering areas allowing more comfort and privacy, extended informal Networking opportunities.
Highlights from NLSDays 2014!
2014 was the second year Nordic Life Science Days was arranged. We are happy to see an increasing in numbers of participants, investors, partnering meetings, sponsors, exhibitors…
NLSDays attracts decision markers - Numbers from 2014
NLSDays are growing - Numbers 2013 vs 2014
Some Confirmed Speakers
Prof. Anders Hamsten, Vice-Chancellor of Karolinska Institutet, Sweden
Dr. Cecilia Schott, Head Personalized HealthCare, Corporate Development & Ventures at AstraZeneca, USA
Dr. Carlos Camozzi, CMO, Orphazyme, Denmark
Dr. Jukka-Pekka Luostarinen, CEO at Relaxbirth Oy, Finland
Dr. Johan Christenson, Partner, HealthCap, Sweden
Mr. Jaanus Pikani, Chairman of ScanBalt, Finland
Dr. Martin Smit, Director of The Graduate School of Medical Sciences at the University Medical Center Groningen, The Netherlands
Ms. Susanne Ås Sivborg, Director General and President, The Swedish Patent and Registration Office Sweden
Mr. Jan-Olov Jacke, VP Finance, Global Products & Portfolio Strategy and R&D at AstraZeneca, UK
Mr. Anders Ekholm, Deputy Director of the Swedish Institute for Future Studies, Sweden
Mr. David Phillips, VP and Partner, SROne GSK Corporate Venture, UK
Dr. Timothy Fisher, Director, Search and Evaluation, BMS, USA
Dr. Nina Rawal, Investment Manager Life Sciences, Industrifonden, Sweden
Dr. Anna Christine Larsen, Scientific Officer, Innovationsfonden, Denmark
Dr. Max Fehlmann, President & CEO NEOMED Institute, Canada
Mr. Adam Kostyal, SVP Nasdaq OMX, Sweden
Dr. Stefan Simianer, Senior Director International Clinical Development AbbVie, USA